Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FAZ | 5.14 | 0.31 | +6.42% |
| Direxion Daily Financial Bear 3X ETF | |||
| IGOV | 42.29 | -0.30 | -0.70% |
| iShares International Treasury Bond ETF | |||
| NAN | 11.26 | -0.11 | -0.95% |
| Nuveen New York Quality Municipal Income Fund | |||
| IQM | 69.82 | -0.96 | -1.36% |
| Franklin Intelligent Machines ETF | |||
| MDY | 550.57 | -8.62 | -1.54% |
| SPDR® S&P MIDCAP 400 ETF Trust | |||
A.I.dvisor tells us that VACBF and EYEN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and EYEN's prices will move in lockstep.
| Ticker / NAME | Correlation To VACBF | 1D Price Change % | ||
|---|---|---|---|---|
| VACBF | 100% | N/A | ||
| EYEN - VACBF | 32% Poorly correlated | -8.61% | ||
| SPHRY - VACBF | 27% Poorly correlated | N/A | ||
| RVPH - VACBF | 22% Poorly correlated | -6.88% | ||
| ZBIO - VACBF | 21% Poorly correlated | -8.75% | ||
| BPTSY - VACBF | 20% Poorly correlated | N/A | ||
More | ||||